Differentialindikation bei der behandlung der zwangsstorungen

Translated title of the contribution: Differential indication in the treatment of obsessive-compulsive disorder

A. Kordon*, F. Hohagen

*Corresponding author for this work


    Obsessive-compulsive disorder is a frequent psychiatric disease, with neurobiological and psychological factors contributing to its genesis. The drugs of choice in somatic treatment of obsessive-compulsive patients are serotonin reuptake inhibitors, whereas behaviour therapy is the preferred psychotherapeutic approach. A combination of behaviour therapy with serotonin reuptake inhibitors is indicated in case of predominance of obsessions and if depressions are present. Following successful combined treatment, behaviour therapy appears to exert an additional protective effect against relapse.

    Translated title of the contributionDifferential indication in the treatment of obsessive-compulsive disorder
    Original languageGerman
    Issue number7
    Pages (from-to)455-457
    Number of pages3
    Publication statusPublished - 1999

    Research Areas and Centers

    • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


    Dive into the research topics of 'Differential indication in the treatment of obsessive-compulsive disorder'. Together they form a unique fingerprint.

    Cite this